Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bangkok Dusit Medical Ser...

    PNK: BDUUF · Real-Time Price · USD
    0.66
    0.00 (0.00%)
    At close: May 06, 2025, 10:00 PM

    Bangkok Dusit Medical Services Public Income Statement

    Financials in THB. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 107.87B 106.81B 105.07B 103.45B 100.85B 97.98B 95.27B 92.96B 91.93B 90.05B 86.02B 81.41B 74.45B 70.68B 67.74B 64.36B
    Cost of Revenue
    		 68.07B 67.42B 66.26B 65.03B 63.41B 61.78B 60.29B 59B 58.33B 57.1B 55.25B 52.86B 49.46B 48.34B 46.38B 44.47B
    Gross Profit
    		 39.8B 39.39B 38.82B 38.43B 37.44B 36.21B 34.98B 33.96B 33.6B 32.95B 30.77B 28.55B 24.99B 22.35B 21.36B 19.89B
    Operating Income
    		 20.18B 20.02B 19.55B 19.35B 18.94B 17.93B 17.31B 16.88B 16.99B 16.5B 15.51B 13.96B 11.23B 11.78B 10.81B 9.71B
    Interest Income
    		 174.8M 187.81M 195.8M 195.87M 173.47M 153.32M 124.09M 93.01M 79.82M 61.93M 56.1M 72.35M 73.14M 70.72M 61.81M 41.08M
    Pretax Income
    		 20.32B 20.15B 19.66B 19.43B 18.65B 17.57B 16.88B 16.4B 16.48B 15.96B 14.94B 13.37B 10.59B 11.13B 10.17B 8.97B
    Net Income
    		 15.99B 15.61B 15.25B 14.97B 14.36B 13.52B 13.02B 12.63B 12.61B 12.13B 11.25B 10.04B 7.94B 7.69B 6.98B 5.98B
    Selling & General & Admin
    		 20.83B 20.54B 20.34B 20.07B 19.81B 19.55B 18.94B 18.26B 17.65B 17.41B 16.43B 15.77B 15.03B 14.24B 13.99B 13.59B
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 -1.22B -782.01M -377.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 190.18M
    Operating Expenses
    		 19.61B 19.38B 19.29B 19.11B 18.55B 18.3B 17.69B 17.1B 16.62B 16.46B 15.27B 14.59B 13.77B 12.98B 12.98B 12.61B
    Interest Expense
    		 433.39M 451.71M 471.51M 495.13M 546.59M 588.98M 620.79M 637.8M 632.07M 636.39M 654.86M 691.79M 728.46M 765.45M 807.88M 837.67M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 87.68B 86.8B 85.55B 84.14B 81.96B 80.08B 77.98B 76.1B 74.95B 73.57B 70.52B 67.45B 63.23B 61.32B 59.36B 57.09B
    Income Tax Expense
    		 3.79B 3.99B 3.86B 3.92B 3.75B 3.52B 3.32B 3.2B 3.23B 3.17B 2.99B 2.68B 2.1B 2.9B 2.73B 2.58B
    Shares Outstanding (Basic)
    		 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B
    Shares Outstanding (Diluted)
    		 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B 15.89B
    EPS (Basic)
    		 1.01 0.99 0.96 0.94 0.90 0.85 0.82 0.80 0.80 0.77 0.72 0.64 0.50 0.48 0.43 0.37
    EPS (Diluted)
    		 1.01 0.99 0.96 0.94 0.90 0.85 0.82 0.80 0.80 0.77 0.72 0.64 0.50 0.48 0.43 0.37
    EBITDA
    		 26.51B 26.25B 25.7B 25.44B 25.05B 23.99B 23.35B 22.93B 23.06B 22.62B 21.72B 20.29B 17.64B 18.27B 17.37B 16.21B
    EBIT
    		 20.76B 20.61B 20.14B 19.94B 19.2B 18.16B 17.5B 17.04B 17.11B 16.6B 15.59B 14.06B 11.32B 11.89B 10.98B 9.81B
    Depreciation & Amortization
    		 6.13B 6.03B 5.95B 5.9B 5.85B 5.83B 5.85B 5.89B 5.95B 6.02B 6.13B 6.23B 6.32B 6.37B 6.39B 6.4B

    Add to Watchlist